Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study of Nivolumab and Chemotherapy Combination for Patients with Refractory Hodgkin’s Lymphoma

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Poland
  • Study of Ruxolitinib with Brentuximab or Pembrolizumab for Patients with Relapsed or Refractory Classical Hodgkin Lymphoma

    Not recruiting

    2 1 1 1
    Italy
  • Study of Pembrolizumab for Patients with Relapsed or Refractory Classical Hodgkin’s Lymphoma or Primary Mediastinal Large B-cell Lymphoma

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    Czechia Italy Poland